Search results
Results from the WOW.Com Content Network
AstraZeneca's primary listing is on the London Stock Exchange and is a constituent of the FTSE 100 Index; it also has a secondary listing on the Nasdaq Stockholm. It is also listed on the American Nasdaq and is a Nasdaq-100 company. AstraZeneca has one of the highest market capitalisations of pharmaceutical companies worldwide. [12]
The consolidation of AstraZeneca's global R&D footprint will have an impact on sites in the United States. About 1,200 positions will leave Wilmington, while there will be an increase of about 300 ...
Jane Osbourn, OBE, is a scientist and former chair of the UK BioIndustry Association. [1]A Natural Sciences graduate of Queens' College, Cambridge, Osbourn completed several post-graduate qualifications before moving into industry at Cambridge Antibody Technology, that became MedImmune and AstraZeneca.
Masimirembwa was born in 1967 in Zimbabwe [5] and received his BSc (Hons) and DPhil degrees in Biochemistry from the University of Zimbabwe in 1993. [6] Fascinated by the then-emerging field of pharmacogenetics, he conducted studies at the Karolinska Institute in Sweden in 1995, [5] where he earned his PhD in Medical Biochemistry and Biophysics.
Golden triangle universities generally do well on international rankings, which strongly reflect research performance. Some global rankings, such as those produced by Times Higher Education (THE) and QS, correct for the sizes of institutions in calculating their results but others, such as the Academic Ranking of World Universities (ARWU), make ...
In 2013, the company formed a partnership with AstraZeneca to develop treatments for cardiovascular, metabolic, and renal diseases, as well as cancer. Moderna was also awarded a $25,000,000 grant by DARPA through a program Autonomous Diagnostics to Enable Prevention and Therapeutics: Prophylactic Options to Environmental and Contagious Threats ...
The International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, a 2015 Swiss NGO of pharmaceutical companies and others, defined a contract research organization (CRO), specifically pertaining to clinical trials services as: [8]: 10 "A person or an organization (commercial, academic, or other) contracted by the sponsor to perform one or ...
For services to UK Resilience and International Science Relationships. David Winton Harding. For services to Philanthropy. Professor John Anthony Hardy, FRS, Chair of the Molecular Biology of Neurological Disease, University College London. For services to Human Health in Improving Understanding of Dementia and Neurodegenerative Diseases.